SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)
ACAD 25.04+0.9%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (282)5/26/2006 12:15:55 PM
From: scaram(o)uche  Read Replies (2) of 588
 
My personal belief is that "grass equivalents" would contain THC and active THC variants that have differential activity at the two major receptors. I also fee that it's an open question, receptors other than CB1 and CB2 may be tickled by plant components.

1. It's a single study, and thus doesn't "mean" anything. One just watches and learns, in context??

2. It's an induced model of injury, and the antagonist ("grass" is an agonist) "decreased the wound-healing response".

So..... first blush, an agonist might not be so good if you're liver is fibrosing, but they're also discussing upside.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News